Incyte
North America, Delaware, United States, Wilmington
Description
Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs.
Investor Profile
Incyte has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Medical, Biotechnology, Life Science.
Stage Focus
- Seed (20%)
- Series B (20%)
- Series Unknown (20%)
- Post Ipo Equity (20%)
- Corporate Round (20%)
Country Focus
- United States (80%)
- United Kingdom (20%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Medical
- Biotechnology
- Life Science
- Health Care
- Therapeutics
- E-learning
- Information Technology
- Pharmaceutical
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Incyte frequently co-invest with?
What are some of recent deals done by Incyte?
Find More Investors Like Incyte
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
